{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["ADME properties", "COVID-19", "Medicinal plants", "Molecular docking", "Molecular dynamics"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "34315340", "DateCompleted": {"Year": "2022", "Month": "12", "Day": "23"}, "DateRevised": {"Year": "2023", "Month": "02", "Day": "17"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "07", "Day": "27"}], "Language": ["eng"], "ELocationID": ["10.1080/07391102.2021.1957712"], "Journal": {"ISSN": "1538-0254", "JournalIssue": {"Volume": "40", "Issue": "21", "PubDate": {"Year": "2022"}}, "Title": "Journal of biomolecular structure & dynamics", "ISOAbbreviation": "J Biomol Struct Dyn"}, "ArticleTitle": "Combined molecular docking and dynamics simulations studies of natural compounds as potent inhibitors against SARS-CoV-2 main protease.", "Pagination": {"StartPage": "11264", "EndPage": "11273", "MedlinePgn": "11264-11273"}, "Abstract": {"AbstractText": ["Main protease (Mpro) of SARS-CoV-2 is a key CoV enzyme that plays a pivotal role in mediating viral replication and transcription, making it an attractive drug target for SARS-CoV-2 the new strain of coronavirus. In this study, we evaluated biologically active compounds present in medicinal plants as potential SARS-CoV-2 Mpro inhibitors, using a molecular docking study with Autodock Vina software. Top seven compounds <i>Afzelin</i>, <i>Phloroglucinol</i>, <i>Myricetin-3-O- rutinosid Tricin 7-neohesperidoside</i>, <i>Silybin</i>, <i>Kaempferol</i> and <i>Silychristin</i> among 50 molecules of natural Origin (Algerian Medicinal plants) were selected which had better and significantly low binding energy as compared to the reference molecule with binding affinities of -9.3, -9.3, -9, -8.9, -8.5, 8.3 and -8.3\u2009kcal mol<sup>-1</sup> respectively. Then, we analyzed the ADME properties of the best 7 ligands using the Web server SwissADME. Two of small molecules have been shown to be the ideal candidates for further drug development. Finally, the stability of the both compounds complexed with Mpro was validated through molecular dynamics (MD) simulation, they displayed stable trajectory (RMSD, RMSF) and molecular properties with consistent interaction profile in molecular dynamics simulations, moreover, <i>Silybin</i> could form more stable complex with Mpro than <i>Silychristin</i>.Communicated by Ramaswamy H. Sarma."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Group of Computational and Medicinal Chemistry, LMCE Laboratory, University of Biskra, Biskra, Algeria."}], "LastName": "Ouassaf", "ForeName": "Mebarka", "Initials": "M"}, {"Identifier": ["0000-0002-6949-4518"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Group of Computational and Medicinal Chemistry, LMCE Laboratory, University of Biskra, Biskra, Algeria."}, {"Identifier": [], "Affiliation": "Centre de Recherche en Sciences Pharmaceutiques (CRSP) la nouvelle ville Ali Mendjeli, Constantine, Algeria."}], "LastName": "Belaidi", "ForeName": "Salah", "Initials": "S"}, {"Identifier": ["0000-0003-2344-5101"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Physical Chemistry of Materials, Faculty of Sciences Ben M'Sik, Hassan II University of Casablanca, Casablanca, Morocco."}], "LastName": "Chtita", "ForeName": "Samir", "Initials": "S"}, {"Identifier": ["0000-0002-3978-7635"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "VTRS Laboratory, Faculty of Sciences and Technology, University of El Oued, El Oued, Algeria."}], "LastName": "Lanez", "ForeName": "Touhami", "Initials": "T"}, {"Identifier": ["0000-0002-9457-6515"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Agricultural Microbiology, Faculty of Agricultural Sciences, Aligarh Muslim University, Aligarh, Uttar Pradesh, India."}], "LastName": "Abul Qais", "ForeName": "Faizan", "Initials": "F"}, {"Identifier": ["0000-0002-7230-3962"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Interdisciplinary Biotechnology Unit, Aligarh Muslim University, Aligarh, India."}], "LastName": "Md Amiruddin", "ForeName": "Hashmi", "Initials": "H"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "J Biomol Struct Dyn", "NlmUniqueID": "8404176", "ISSNLinking": "0739-1102"}, "ChemicalList": [{"RegistryNumber": "EC 3.4.22.-", "NameOfSubstance": "3C-like proteinase, SARS-CoV-2"}, {"RegistryNumber": "0", "NameOfSubstance": "Protease Inhibitors"}, {"RegistryNumber": "4RKY41TBTF", "NameOfSubstance": "Silybin"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": [], "DescriptorName": "Molecular Dynamics Simulation"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Protease Inhibitors"}, {"QualifierName": ["drug effects"], "DescriptorName": "SARS-CoV-2"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Silybin"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2021", "Month": "7", "Day": "29", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "12", "Day": "21", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "7", "Day": "28", "Hour": "5", "Minute": "30"}], "PublicationStatus": "ppublish", "ArticleIdList": ["34315340", "10.1080/07391102.2021.1957712"]}}], "PubmedBookArticle": []}